|Bid||18.58 x 800|
|Ask||18.61 x 2200|
|Day's Range||18.28 - 18.73|
|52 Week Range||7.32 - 20.81|
|Beta (5Y Monthly)||2.87|
|PE Ratio (TTM)||5.42|
|Earnings Date||Nov 01, 2021|
|Forward Dividend & Yield||0.44 (2.37%)|
|Ex-Dividend Date||Aug 06, 2021|
|1y Target Est||24.25|
Subscribe to Yahoo Finance Plus to view Fair Value for CUROLearn more
WICHITA, Kan., October 20, 2021--CURO Group Holdings Corp. (NYSE: CURO) ("CURO"), a tech-enabled, omni-channel consumer finance company serving a full spectrum of non-prime and prime consumers in the U.S. and Canada, announced today that its third quarter 2021 financial results will be released after the market closes on Monday, November 1, 2021.
Michael Mcknight, Director at Curo Group Holdings (NYSE:CURO), made a large insider sell on October 14, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Mcknight sold 79,811 shares of Curo Group Holdings at prices ranging from $18.05 to $18.88. The total transaction amounted to $1,472,560. Following the transaction, Mcknight still owns 5,940,582 shares of Curo Group Holdings worth $112,158,188. Curo Group Holdi
TORONTO, September 28, 2021--Flexiti Financial Inc. ("Flexiti"), a leading provider of buy now, pay later point-of-sale consumer financing solutions for retailers, announced today it has launched its 0% interest1 financing solution at London Drugs. This launch follows a successful pilot program in select London Drugs locations that launched earlier this year.